Hormonal therapy with estradiol and testosterone implants: bone protection?

Area of Science:

• Endocrinology
• Bone Metabolism
• Geriatric Medicine

Background:

• Postmenopausal osteoporosis is a significant health concern.
• Hormone replacement therapy is a common treatment for menopausal symptoms and bone loss.
• The combined effects of estradiol and testosterone on bone mineral density (BMD) require further investigation.

Purpose of the Study:

• To evaluate the impact of estradiol and testosterone hormonal implants on BMD in postmenopausal women.
• To compare BMD changes in women using hormonal implants versus those not receiving hormonal therapy.

Main Methods:

• A prospective cohort study involving 61 postmenopausal women.
• Participants were divided into two groups: Group 1 (34 women with hormonal implants) and Group 2 (27 women without hormonal therapy).
• Bone mineral density (BMD) was assessed using Dual-energy X-ray absorptiometry at baseline and after one year.

Main Results:

• In Group 1, lumbar spine BMD showed no significant change (1.123 ± 0.16 to 1.144 ± 0.18 kg/m², p=0.39), and femur BMD showed a trend towards increase (0.922 ± 0.16 to 0.957 ± 0.12 kg/m², p=0.076).
• In Group 2, lumbar spine BMD slightly decreased (1.064 ± 0.2 to 1.001 ± 0.23 kg/m², p=0.112), and femur BMD significantly decreased (0.928 ± 0.14 to 0.881 ± 0.15 kg/m², p=0.046).
• Comparison between groups indicated that hormonal implants promoted bone protection.

Conclusions:

• The combination of estradiol and testosterone in hormonal implants demonstrated a bone-protective effect in postmenopausal women over a one-year period.
• This finding suggests that combined hormone therapy may be beneficial in preventing bone loss in this population.
• Further research with longer follow-up periods is warranted to confirm these results.